Because of the COVID-19 situation, VIB has decided that the first edition of Tumor Heterogeneity, Plasticity and Therapy will be a virtual one. The conference will be held on May 5-6, 2021 and tickets are now available on the conference website.
The inaugural edition will cover the following topics:
- Plasticity in initiation, progression and metastasis
- Heterogeneity and reprogramming of the tumor immune- and microenvironment
- Adaptation and resistance to targeted therapies
- Adaptation and resistance to immunotherapies
What can you expect from this virtual conference?
- 18 leading cancer researchers presenting their latest discoveries
- An opportunity to have one-on-one video chats with these speakers during the 'Meet the Speaker" sessions
- A chance to submit your own research for one of the four plenary talk slots or for the poster sessions
- A possibility to win the Nature Poster Prize
- The option to join a VIB Conference from anywhere
Tumors are complex and evolving ecosystems composed of a wide variety of cell types, in addition to the cancer cells themselves. Increasing evidence indicates that the bi-directional interplay between tumor cells and their tumor microenvironment shape tumor evolution and therapy resistance.
Within a tumor, many cancer cells differ from each at the (epi-)genomic, transcriptional and proteomic level, as well as phenotypically and functionally. Tumor heterogeneity represents a major hurdle for therapy, which may only target a subset of tumor cells. In addition, cancer cell plasticity permits rapidly adaption to therapeutics and development of tolerance and resistance, presenting additional challenges for both targeted and immunotherapies.
Intrigued? Visit the conference website for more info:
